Table I.
Countries and Regulatory Authorities Considered in this Review
| Country | Regulatory authority | Website |
|---|---|---|
| Australia (17) | Therapeutic Goods Administration (TGA) | http://www.tga.gov.au/ |
| Brazil (18) | National Health Surveillance Agency (ANVISA) | http://www.anvisa.gov.br/ |
| Canada (19) | Health Canada | http://www.hc-sc.gc.ca/ |
| China (20) | National Institute for the Control of Pharmaceutical and Biological Products | http://www.nicpbp.org.cn/cmsweb/ |
| Europe (5) | European Medicines Agency (EMA) | http://www.ema.europa.eu/ |
| India (21) | Central Drugs Standard Control Organization (CDSCO) | http://cdsco.nic.in/ |
| Japan, (6,22–24) | Pharmaceuticals and Medical Devices Agency (PMDA) | http://www.pmda.go.jp/ |
| Mexico (25) | Ministry of Health | http://www.salud.gob.mx/ |
| Russia (5) | Ministry of Health | http://government.ru/ |
| Thailand (26) | Ministry of Public Health | http://eng.moph.go.th/ |
| Turkey (27) | Ministry of Health | http://www.saglik.gov.tr/ |
| South Africa (28) | Medicines Control Council (MCC) | http://www.mccza.com/ |
| South Korea (29) | Ministry of Food and Drug Safety (MFDS) | http://www.mfds.go.kr/ |
| United States (4,14) | US Food and Drug Administration (FDA) | http://www.fda.gov/ |